Is There a Unified Etiology of Hypoplastic Left Heart Syndrome? Evaluating Genetic, Structural, and Hemodynamic

Reese Leonhard1,2, Zachary Beau Phillips1,2, Jamie Wilson1

  • 1Congenital Heart Center, Departments of Surgery and Pediatrics, UF Health Shands Hospital, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32608, USA.

Insights

Hypoplastic left heart syndrome (HLHS) likely results from complex interactions between genetic susceptibility, altered blood flow, and in utero environmental factors. Different underlying causes and timing of insults explain the varied HLHS phenotypes.

Area of Science:

  • Cardiovascular Medicine
  • Developmental Biology
  • Genetics

Background:

  • Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect characterized by underdevelopment of the left heart structures.
  • HLHS is typically lethal in neonates without intervention, and its etiology remains incompletely understood, with no single theory explaining its phenotypic variability.
  • Existing theories fail to fully elucidate the precipitating events leading to HLHS development.

Purpose of the Study:

  • To critically evaluate leading theories on HLHS pathogenesis, including hemodynamic disturbances, primary myocardial defects, valvar malformations, and genetic/epigenetic factors.
  • To propose a novel, data-driven framework for understanding HLHS pathogenesis and its subtypes.
  • To identify potential unifying explanations for HLHS etiology by examining cardiac progenitor cell dysregulation.

Main Methods:

  • Review of human fetal imaging, histopathology, genetic studies, and animal models.
  • Critical analysis of findings as potential causal factors for HLHS patterns and phenotypes.
  • Evaluation of strengths and weaknesses of existing theoretical models (flow theory, myocardial/valve-first models, genetic studies, multifactorial framework).

Main Results:

  • The flow theory is supported by animal models but doesn't explain initial causes or histological features.
  • Myocardial and valve-first models lack strong experimental bases for mediating HLHS.
  • Genetic studies identify candidate mutations but show incomplete penetrance; a multifactorial framework integrates mechanisms but lacks research pathways.

Conclusions:

  • No single hypothesis fully explains HLHS initiation, progression, or clinical presentation.
  • HLHS spectrum reflects a complex interplay of genetic susceptibility, flow-dependent remodeling, and in utero environmental factors.
  • A multifactorial model offers the most coherent explanation for HLHS heterogeneity, with timing of insult critical for determining subtype.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...